StonvexLoading…
StonvexStonvexStonvexCore line items from OLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.58B | $6.78B | $5.12B | $3.40B |
Operating Income | $-78.30M | $5.30M | $161.80M | $79.00M |
Net Income | $-83.00M | $-101.10M | $42.10M | $-1.60M |
EPS (Diluted) | $-0.73 | $-0.88 | $0.37 | $0.00 |
Total Assets | $7.35B | $7.33B | $7.60B | $7.67B |
Total Liabilities | $5.62B | $5.46B | $5.61B | $5.68B |
Cash & Equivalents | $192.20M | $167.60M | $140.30M | $223.80M |
Free Cash Flow OCF − CapEx | $-92.30M | $247.90M | $-10.50M | $33.90M |
Shares Outstanding | 113.90M | 113.60M | 114.10M | 114.60M |